2010
March 1, 2010
AnaptysBio Announces Third Antibody Collaboration for 2010
February 8, 2010
AnaptysBio Announces Collaboration with Merck & Co., Inc.
January 11, 2010
AnaptysBio Announces Agreement with Roche to Develop Novel Antibodies
2009
November 17, 2009
AnaptysBio Names Director of Cell Biology; Joins from Regeneron,
Adds Extensive Therapeutic Antibody Discovery Credentials
February 3, 2009
AnaptysBio names Vice President of Preclinical Development
January 12, 2009
AnaptysBio adds three to senior management team
2007
November 8, 2007
AnaptysBio raises over $33 million in Series B financing
May 15, 2007
AnaptysBio acquires key intellectual property for novel antibody discovery
April 30, 2007
AnaptysBio names former XOMA executive as chairman and CEO